atomoxetine hydrochloride has been researched along with Disease Models, Animal in 50 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (18.00) | 29.6817 |
| 2010's | 35 (70.00) | 24.3611 |
| 2020's | 6 (12.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Ciucci, MR; Hoffmeister, JD; Kelm-Nelson, CA | 1 |
| Harkin, A; McNamara, C; O'Neill, E; Yssel, JD | 1 |
| Choudhury, ME; Eguchi, M; Fukuda, M; Ishii, E; Jogamoto, T; Kihara, N; Kubo, M; Miyanishi, K; Nagai, M; Nomoto, M; Sato, A; Shimizu, YI; Tanaka, J; Utsunomiya, R; Yano, H | 1 |
| Cheng, Y; Lu, H; Ma, HX; Shen, Y; Sun, JL; Zhang, HH; Zhao, HT | 1 |
| Adil, KJ; Cheong, JH; Han, SH; Jeon, SJ; Kim, HJ; Kim, HY; Kim, R; Kwon, KJ; Mabunga, DFN; Park, D; Ryu, O; Shin, CY; Valencia, S | 1 |
| Ahn, JH; Choi, SY; Hong, S; Kang, IJ; Kim, SK; Kim, YH; Kim, YM; Lee, CH; Lee, TK; Park, JH; Won, MH | 1 |
| Feng, HJ; Zhang, H; Zhao, H | 1 |
| Cheong, JH; de la Peña, JB; Dela Peña, I; Dela Peña, IJ; Han, DH; Kim, BN; Kim, HJ; Ryu, JH; Shin, CY | 1 |
| Cotten, JF; Feng, HJ; Long, X; Zhao, H | 1 |
| Cichocki, A; Hasegawa, M; Hiroyama, S; Horiuchi, M; Jurica, P; Li, J; Nishitomi, K; Ogawa, K; Struzik, ZR; Takahara, Y; Yokota, T | 1 |
| Barbaros, MB; Can, ÖD; Demir Özkay, Ü; Turan Yücel, N; Üçel, Uİ | 1 |
| Eddy, JB; Good, MA; Humby, T; Reichelt, AC; Wilkinson, LS | 1 |
| Dwoskin, LP; Jordan, CJ; Kantak, KM; Somkuwar, SS | 1 |
| Chadman, KK; Guariglia, SR; Stapley, NW | 1 |
| Brennan, CH; Brock, AJ; Parker, MO; Sudwarts, A | 1 |
| Gupta, S; Sharma, B; Sharma, BM; Singh, P | 1 |
| Ago, Y; Fujita, K; Hasebe, S; Higashino, K; Matsuda, T; Takuma, K; Umehara, M | 1 |
| Davies, W; Eddy, JB; Humby, T; Ojarikre, OA; Trent, S; Wilkinson, LS | 1 |
| Barnes, SA; Grayson, B; Harte, MK; Marsh, S; Marshall, KM; Neill, JC; Tomlinson, A | 1 |
| Alén, F; Antón, M; de Heras, RG; Gorriti, MÁ; Orio, L; Pavón, FJ; Pozo, MÁ; Ramírez-López, MT; Rodríguez de Fonseca, F; Serrano, A | 1 |
| Carroll, ME; Zlebnik, NE | 1 |
| Corbit, LH; Leung, HT | 1 |
| Guerrero-Álvarez, Á; Juárez, J | 1 |
| Ahn, JH; Chen, BH; Cho, JH; Kim, IH; Kim, SK; Kim, YM; Lee, CH; Lee, JC; Lee, YL; Park, JH; Shin, BN; Tae, HJ; Won, MH | 1 |
| Ago, Y; Hara, Y; Hasebe, S; Hashimoto, H; Katashiba, K; Matsuda, T; Onaka, Y; Takano, E; Takuma, K; Taruta, A | 1 |
| Adams, WK; Kaur, S; Lam, FC; Muthukrishna, M; Riparip, LK; Rosi, S; Vonder Haar, C; Winstanley, CA | 1 |
| Compagno, E; Di Cesare Mannelli, L; Ghelardini, C; Grassi, G; Micheli, L; Pallanti, S; Righi, L | 1 |
| Darling, J; McGaughy, J; Newman, LA | 1 |
| Izumi, T; Ohmura, Y; Tsutsui-Kimura, I; Yamaguchi, T; Yoshida, T; Yoshioka, M | 1 |
| Baldridge, BR; Brown, DR; Li, SG; Li, WY; Nesselroade, KP; Randall, DC; Silcox, DL; Smith, R; Strang, SE | 1 |
| Arra, C; Carboni, E; Carnevale, UA; Ibba, M; Melisi, D; Ruocco, LA; Sadile, AG; Schirru, C; Treno, C | 1 |
| Arai, Y; Hiraga, H; Murai, S; Nakagawasai, O; Niijima, F; Saito, H; Tadano, T; Tan-No, K; Watanabe, H | 1 |
| Arnsten, AF; Gamo, NJ; Wang, M | 1 |
| Attali, P; Bienaymé, H; Ferté, J; Lluel, P; Ocaña, AV; Palea, S; Pérez-Martínez, FC; Rekik, M; Vela-Navarrete, R; Virseda, J | 1 |
| Ahn, HS; Cheong, JH; dela Peña, IC; Park, IH; Ryu, JH; Shin, CY | 1 |
| Araki, H; Kawasaki, H; Suemaru, K; Takechi, K | 1 |
| Bowers, MS; Corbit, LH; Janak, PH | 1 |
| Drago, F; Mazzola, C; Micale, V; Salomone, S; Tamburella, A | 1 |
| Bally-Cuif, L; Chaminade, M; Coolen, M; Lange, M; Lesch, KP; Merker, S; Norton, W; Proft, F; Schmitt, A; Vernier, P | 1 |
| Bucci, DJ; Eggleston, RL; Robinson, AM | 1 |
| Cassidy, E; Dommett, EJ; Turner, M; Wilding, E | 1 |
| Terry, AV; Wilson, CA | 1 |
| Bergman, J; Gasior, M; Kallman, MJ; Paronis, CA | 1 |
| Baldessarini, RJ; Moran-Gates, T; Tarazi, FI; Zhang, K | 1 |
| Blondeau, C; Dellu-Hagedorn, F | 1 |
| Davis, JA; Gould, TJ | 1 |
| Lei, GF; Liu, LL; Sun, RP; Wang, GJ; Wang, YW; Yang, J | 1 |
| Hamm, RJ; Reid, WM | 1 |
| Heal, DJ; Kulkarni, RS; Rowley, HL; Smith, SL | 1 |
1 review(s) available for atomoxetine hydrochloride and Disease Models, Animal
| Article | Year |
|---|---|
New perspectives from microdialysis studies in freely-moving, spontaneously hypertensive rats on the pharmacology of drugs for the treatment of ADHD.
Topics: Amphetamine; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Disease Models, Animal; Dopamine; Humans; Methylphenidate; Microdialysis; Norepinephrine; Propylamines; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 2008 |
49 other study(ies) available for atomoxetine hydrochloride and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Manipulation of vocal communication and anxiety through pharmacologic modulation of norepinephrine in the Pink1-/- rat model of Parkinson disease.
Topics: Adrenergic Uptake Inhibitors; Animals; Anxiety; Atomoxetine Hydrochloride; Disease Models, Animal; Humans; Male; Norepinephrine; Parkinson Disease; Protein Kinases; Rats; Rats, Long-Evans; Reboxetine; Vocalization, Animal | 2022 |
Pharmacological targeting of β
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic Uptake Inhibitors; Animals; Anti-Inflammatory Agents; Atomoxetine Hydrochloride; Brain; Clenbuterol; Disease Models, Animal; Formoterol Fumarate; Lipopolysaccharides; Male; Microglia; Motor Activity; Nerve Degeneration; Neurons; Neuroprotective Agents; Parkinsonian Disorders; Rats, Wistar; Receptors, Adrenergic, beta-2 | 2020 |
Lister hooded rats as a novel animal model of attention-deficit/hyperactivity disorder.
Topics: Animals; Atomoxetine Hydrochloride; Attention; Attention Deficit Disorder with Hyperactivity; Disease Models, Animal; Gene Expression Regulation; Guanfacine; Impulsive Behavior; Male; Maze Learning; Prefrontal Cortex; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Rats, Wistar; Social Interaction; Species Specificity | 2020 |
Central deficiency of norepinephrine synthesis and norepinephrinergic neurotransmission contributes to seizure-induced respiratory arrest.
Topics: Acoustic Stimulation; Adrenergic alpha-1 Receptor Antagonists; Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Brain Stem; Brain Waves; Disease Models, Animal; Female; Male; Mice, Inbred DBA; Norepinephrine; Pentylenetetrazole; Prazosin; Receptors, Adrenergic, alpha-1; Respiration; Respiration, Artificial; Respiratory Insufficiency; Seizures; Signal Transduction; Sudden Unexpected Death in Epilepsy; Tyrosine 3-Monooxygenase | 2021 |
Synergistic efficacy and diminished adverse effect profile of composite treatment of several ADHD medications.
Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Disease Models, Animal; Dizocilpine Maleate; Dopamine Uptake Inhibitors; Drug Synergism; Drug Therapy, Combination; Excitatory Amino Acid Antagonists; Fluoxetine; Growth and Development; Methylphenidate; Mice; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Open Field Test; Proto-Oncogene Proteins c-akt; Selective Serotonin Reuptake Inhibitors; Sleep | 2021 |
Atomoxetine Protects Against NMDA Receptor-mediated Hippocampal Neuronal Death Following Transient Global Cerebral Ischemia.
Topics: Animals; Atomoxetine Hydrochloride; bcl-2-Associated X Protein; Cell Death; Disease Models, Animal; Gerbillinae; Hippocampus; Ischemic Attack, Transient; Male; Motor Activity; Neurons; Neuroprotective Agents; Phosphopyruvate Hydratase; Proto-Oncogene Proteins c-bcl-2; Receptors, N-Methyl-D-Aspartate; Time Factors | 2017 |
Atomoxetine, a norepinephrine reuptake inhibitor, reduces seizure-induced respiratory arrest.
Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Death, Sudden; Disease Models, Animal; Mice; Mice, Inbred DBA; Norepinephrine; Respiration Disorders; Seizures | 2017 |
Methylphenidate and Atomoxetine-Responsive Prefrontal Cortical Genetic Overlaps in "Impulsive" SHR/NCrl and Wistar Rats.
Topics: Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Choice Behavior; Disease Models, Animal; Impulsive Behavior; Male; Methylphenidate; Prefrontal Cortex; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Wistar | 2017 |
The effect of atomoxetine, a selective norepinephrine reuptake inhibitor, on respiratory arrest and cardiorespiratory function in the DBA/1 mouse model of SUDEP.
Topics: Acoustic Stimulation; Adrenergic Uptake Inhibitors; Animals; Anticonvulsants; Atomoxetine Hydrochloride; Blood Pressure; Brugada Syndrome; Cardiovascular Agents; Disease Models, Animal; Epilepsy; Female; Heart Rate; Male; Mice, Inbred DBA; Respiration; Respiratory System Agents; Seizures | 2017 |
Semi-Automated Biomarker Discovery from Pharmacodynamic Effects on EEG in ADHD Rodent Models.
Topics: Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Biomarkers; Disease Models, Animal; Electroencephalography; Humans; Linear Models; Methylphenidate; Rats; Rats, Inbred SHR | 2018 |
Antihyperalgesic Activity of Atomoxetine on Diabetes-Induced Neuropathic Pain: Contribution of Noradrenergic and Dopaminergic Systems.
Topics: Animals; Atomoxetine Hydrochloride; Catecholamines; Diabetic Neuropathies; Disease Models, Animal; Hyperalgesia; Male; Motor Activity; Neuralgia; Pain Management; Rats; Receptors, Catecholamine | 2018 |
A novel translational assay of response inhibition and impulsivity: effects of prefrontal cortex lesions, drugs used in ADHD, and serotonin 2C receptor antagonism.
Topics: Aminopyridines; Animals; Atomoxetine Hydrochloride; Disease Models, Animal; Impulsive Behavior; Indoles; Inhibition, Psychological; Male; Methylphenidate; Mice; Prefrontal Cortex; Propylamines; Receptor, Serotonin, 5-HT2C; Serotonin 5-HT2 Receptor Antagonists | 2013 |
Adolescent atomoxetine treatment in a rodent model of ADHD: effects on cocaine self-administration and dopamine transporters in frontostriatal regions.
Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Cocaine; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Frontal Lobe; Male; Propylamines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reinforcement Schedule; Self Administration | 2013 |
Cued and contextual fear conditioning in BTBR mice is improved with training or atomoxetine.
Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Autistic Disorder; Conditioning, Classical; Cues; Disease Models, Animal; Fear; Learning; Male; Mice; Propylamines; Social Behavior | 2013 |
Atomoxetine reduces anticipatory responding in a 5-choice serial reaction time task for adult zebrafish.
Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Choice Behavior; Disease Models, Animal; Female; Impulsive Behavior; Male; Methylphenidate; Propylamines; Reaction Time; Zebrafish | 2014 |
Modulation of transient receptor potential vanilloid subtype 1 (TRPV1) and norepinephrine transporters (NET) protect against oxidative stress, cellular injury, and vascular dementia.
Topics: Adrenergic Uptake Inhibitors; Animals; Antioxidants; Atomoxetine Hydrochloride; Benzaldehydes; Brain; Brain Ischemia; Dementia, Vascular; Disease Models, Animal; Female; Male; Maze Learning; Mice; Norepinephrine Plasma Membrane Transport Proteins; Oxidative Stress; Propylamines; TRPV Cation Channels | 2014 |
Atomoxetine-induced increases in monoamine release in the prefrontal cortex are similar in spontaneously hypertensive rats and Wistar-Kyoto rats.
Topics: Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Disease Models, Animal; Dopamine; Male; Norepinephrine; Potassium; Prefrontal Cortex; Propylamines; Rats, Inbred SHR; Rats, Inbred WKY; Serotonin | 2014 |
Genetic and pharmacological modulation of the steroid sulfatase axis improves response control; comparison with drugs used in ADHD.
Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Agents; Central Nervous System Stimulants; Coumarins; Dehydroepiandrosterone Sulfate; Disease Models, Animal; Enzyme Inhibitors; Inhibition, Psychological; Male; Methylphenidate; Mice, Transgenic; Neuropsychological Tests; Propylamines; Psychomotor Performance; Steryl-Sulfatase; Sulfonamides | 2014 |
Pay attention to impulsivity: modelling low attentive and high impulsive subtypes of adult ADHD in the 5-choice continuous performance task (5C-CPT) in female rats.
Topics: Analysis of Variance; Animals; Atomoxetine Hydrochloride; Attention; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Choice Behavior; Disease Models, Animal; Female; Impulsive Behavior; Methylphenidate; Propylamines; Rats; Reaction Time | 2014 |
The administration of atomoxetine during alcohol deprivation induces a time-limited increase in alcohol consumption after relapse.
Topics: Adrenergic Uptake Inhibitors; Alcohol Drinking; Analysis of Variance; Animals; Atomoxetine Hydrochloride; Central Nervous System Depressants; Conditioning, Operant; Disease Models, Animal; Ethanol; Locomotion; Male; Propylamines; Rats; Rats, Wistar; Recurrence; Self Administration | 2014 |
Effects of the combination of wheel running and atomoxetine on cue- and cocaine-primed reinstatement in rats selected for high or low impulsivity.
Topics: Animals; Atomoxetine Hydrochloride; Cocaine; Cocaine-Related Disorders; Cues; Disease Models, Animal; Dose-Response Relationship, Drug; Drug-Seeking Behavior; Extinction, Psychological; Female; Impulsive Behavior; Motor Activity; Physical Conditioning, Animal; Propylamines; Rats; Rats, Wistar; Running; Self Administration | 2015 |
Extinction of alcohol seeking is enhanced by compound extinction and the noradrenaline reuptake inhibitor atomoxetine.
Topics: Adrenergic Uptake Inhibitors; Alcoholism; Animals; Atomoxetine Hydrochloride; Behavior, Animal; Conditioning, Classical; Cues; Disease Models, Animal; Drug-Seeking Behavior; Extinction, Psychological; Male; Rats; Rats, Wistar; Reward | 2017 |
Effects of methylphenidate and atomoxetine on impulsivity and motor activity in preadolescent rats prenatally-treated with alcohol.
Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Central Nervous System Depressants; Central Nervous System Stimulants; Delay Discounting; Disease Models, Animal; Ethanol; Female; Fetal Alcohol Spectrum Disorders; Impulsive Behavior; Male; Methylphenidate; Motor Activity; Pregnancy; Prenatal Exposure Delayed Effects; Psychotropic Drugs; Rats, Wistar | 2015 |
Neuroprotection and reduced gliosis by atomoxetine pretreatment in a gerbil model of transient cerebral ischemia.
Topics: Analysis of Variance; Animals; Atomoxetine Hydrochloride; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluoresceins; Gerbillinae; Glial Fibrillary Acidic Protein; Gliosis; Ischemic Attack, Transient; Male; Microfilament Proteins; Neuroprotective Agents; Phosphopyruvate Hydratase | 2015 |
Improvement by methylphenidate and atomoxetine of social interaction deficits and recognition memory impairment in a mouse model of valproic acid-induced autism.
Topics: Animals; Atomoxetine Hydrochloride; Autistic Disorder; Behavior, Animal; Dendritic Spines; Disease Models, Animal; Dopamine; Female; Humans; Interpersonal Relations; Male; Methylphenidate; Mice; Mice, Inbred ICR; Norepinephrine; Prefrontal Cortex; Pregnancy; Receptors, Dopamine D1; Recognition, Psychology; Valproic Acid | 2016 |
Frontal Traumatic Brain Injury in Rats Causes Long-Lasting Impairments in Impulse Control That Are Differentially Sensitive to Pharmacotherapeutics and Associated with Chronic Neuroinflammation.
Topics: Acute Disease; Adrenergic Uptake Inhibitors; Amantadine; Amphetamine; Animals; Atomoxetine Hydrochloride; Brain Injuries, Traumatic; Central Nervous System Stimulants; Chronic Disease; Disease Models, Animal; Disease Progression; Disruptive, Impulse Control, and Conduct Disorders; Dopamine Agents; Frontal Lobe; Male; Motor Activity; Neuroimmunomodulation; Rats, Long-Evans; Severity of Illness Index | 2016 |
Atomoxetine for hoarding disorder: A pre-clinical and clinical investigation.
Topics: Adrenergic Uptake Inhibitors; Adult; Animals; Antidepressive Agents, Second-Generation; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Disease Models, Animal; Female; Fluoxetine; Follow-Up Studies; Hoarding Disorder; Humans; Impulsive Behavior; Locomotion; Male; Mice; Middle Aged; Motor Activity; Psychiatric Status Rating Scales; Rotarod Performance Test; Statistics, Nonparametric | 2016 |
Atomoxetine reverses attentional deficits produced by noradrenergic deafferentation of medial prefrontal cortex.
Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Attention; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Discrimination Learning; Disease Models, Animal; Dose-Response Relationship, Drug; Norepinephrine; Prefrontal Cortex; Propylamines; Psychomotor Performance; Rats; Rats, Long-Evans | 2008 |
The effects of serotonin and/or noradrenaline reuptake inhibitors on impulsive-like action assessed by the three-choice serial reaction time task: a simple and valid model of impulsive action using rats.
Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Behavior, Animal; Choice Behavior; Cyclopropanes; Disease Models, Animal; Dose-Response Relationship, Drug; Fluvoxamine; Impulsive Behavior; Male; Milnacipran; Nicotine; Nicotinic Agonists; Propylamines; Rats; Rats, Wistar; Reaction Time; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors | 2009 |
Atomoxetine changes rat's HR response to stress from tachycardia to bradycardia via alterations in autonomic function.
Topics: Adrenergic Uptake Inhibitors; Analysis of Variance; Animals; Atomoxetine Hydrochloride; Autonomic Nervous System; Blood Pressure; Bradycardia; Conditioning, Classical; Disease Models, Animal; Heart Rate; Propylamines; Rats; Rats, Sprague-Dawley; Stress, Psychological; Tachycardia | 2010 |
Prepuberal subchronic methylphenidate and atomoxetine induce different long-term effects on adult behaviour and forebrain dopamine, norepinephrine and serotonin in Naples high-excitability rats.
Topics: Adrenergic Uptake Inhibitors; Aging; Animals; Atomoxetine Hydrochloride; Attention; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Disease Models, Animal; Dopamine; Male; Maze Learning; Methylphenidate; Norepinephrine; Propylamines; Prosencephalon; Random Allocation; Rats; Serotonin; Time Factors | 2010 |
Effects of atomoxetine on levels of monoamines and related substances in discrete brain regions in mice intermittently deprived of rapid eye movement sleep.
Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Disease Models, Animal; Dopamine; Frontal Lobe; Hyperkinesis; Male; Mice; Mice, Inbred Strains; Movement; Norepinephrine; Propylamines; Sleep Deprivation; Sleep, REM | 2010 |
Methylphenidate and atomoxetine enhance prefrontal function through α2-adrenergic and dopamine D1 receptors.
Topics: Adrenergic Uptake Inhibitors; Animals; Appetitive Behavior; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Brain Mapping; Central Nervous System Stimulants; Child; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Humans; Macaca mulatta; Male; Memory, Short-Term; Methylphenidate; Nerve Net; Orientation; Prefrontal Cortex; Propylamines; Pyramidal Cells; Receptors, Adrenergic, alpha-2; Receptors, Dopamine D1; Saccades | 2010 |
Halothane-anesthetized rabbit: a new experimental model to test the effects of besipirdine and duloxetine on lower urinary tract function.
Topics: Anesthesia; Anesthetics; Animals; Atomoxetine Hydrochloride; Disease Models, Animal; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Electromyography; Female; Halothane; Humans; Indoles; Muscle, Smooth; Norepinephrine; Prazosin; Propylamines; Pyridines; Rabbits; Retrospective Studies; Thiophenes; Urinary Tract; Urinary Tract Infections; Urodynamics | 2011 |
Conditioned place preference studies with atomoxetine in an animal model of ADHD: effects of previous atomoxetine treatment.
Topics: Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Conditioning, Psychological; Disease Models, Animal; Propylamines; Rats; Reward | 2011 |
Regulatory role of the dopamine and norepinephrine transporters in pentylenetetrazol-kindled mice: association with effect of antidepressants.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Atomoxetine Hydrochloride; Bupropion; Depression; Disease Models, Animal; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Kindling, Neurologic; Male; Mice; Mice, Inbred ICR; Norepinephrine Plasma Membrane Transport Proteins; Pentylenetetrazole; Propylamines; Seizures; Swimming | 2011 |
Compound stimulus presentation and the norepinephrine reuptake inhibitor atomoxetine enhance long-term extinction of cocaine-seeking behavior.
Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Cocaine-Related Disorders; Disease Models, Animal; Drug-Seeking Behavior; Extinction, Psychological; Male; Norepinephrine; Propylamines; Rats; Rats, Sprague-Dawley | 2012 |
The selective norepinephrine reuptake inhibitor atomoxetine counteracts behavioral impairments in trimethyltin-intoxicated rats.
Topics: Aging; Animals; Animals, Newborn; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Avoidance Learning; Behavior, Animal; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Male; Memory; Motor Activity; Neurotransmitter Uptake Inhibitors; Norepinephrine; Pregnancy; Prenatal Exposure Delayed Effects; Propylamines; Random Allocation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Trimethyltin Compounds | 2012 |
The ADHD-susceptibility gene lphn3.1 modulates dopaminergic neuron formation and locomotor activity during zebrafish development.
Topics: Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Diencephalon; Disease Models, Animal; Dopamine Uptake Inhibitors; Dopaminergic Neurons; Gene Knockdown Techniques; Methylphenidate; Molecular Imaging; Motor Activity; Nerve Degeneration; Propylamines; Receptors, Peptide; Zebrafish | 2012 |
Physical exercise and catecholamine reuptake inhibitors affect orienting behavior and social interaction in a rat model of attention-deficit/hyperactivity disorder.
Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Attention; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Catecholamines; Disease Models, Animal; Dopamine Uptake Inhibitors; Female; Methylphenidate; Motor Activity; Physical Conditioning, Animal; Propylamines; Rats; Rats, Inbred SHR; Rats, Wistar; Social Behavior | 2012 |
Effects of atomoxetine on locomotor activity and impulsivity in the spontaneously hypertensive rat.
Topics: Adrenergic Uptake Inhibitors; Amphetamine; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Central Nervous System Sensitization; Disease Models, Animal; Impulsive Behavior; Male; Maze Learning; Motor Activity; Neuropsychological Tests; Propylamines; Rats; Rats, Inbred SHR | 2013 |
Variable maternal stress in rats alters locomotor activity, social behavior, and recognition memory in the adult offspring.
Topics: Adrenergic Uptake Inhibitors; Amphetamine; Animals; Antipsychotic Agents; Atomoxetine Hydrochloride; Behavior, Animal; Benzylidene Compounds; Disease Models, Animal; Female; Humans; Male; Maze Learning; Mental Disorders; Motor Activity; Nicotinic Agonists; Pregnancy; Prenatal Exposure Delayed Effects; Propylamines; Pyridines; Rats; Rats, Sprague-Dawley; Recognition, Psychology; Risperidone; Social Behavior; Stress, Physiological | 2013 |
Evaluation of the reinforcing effects of monoamine reuptake inhibitors under a concurrent schedule of food and i.v. drug delivery in rhesus monkeys.
Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Brain; Central Nervous System Stimulants; Cocaine; Desipramine; Dextroamphetamine; Disease Models, Animal; Dose-Response Relationship, Drug; Eating; Female; Infusion Pumps; Macaca mulatta; Methylphenidate; Propylamines; Reinforcement, Psychology; Self Administration; Substance-Related Disorders | 2005 |
Atomoxetine blocks motor hyperactivity in neonatal 6-hydroxydopamine-lesioned rats: implications for treatment of attention-deficit hyperactivity disorder.
Topics: Adrenergic Agents; Adrenergic Uptake Inhibitors; Analysis of Variance; Animals; Animals, Newborn; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Disease Models, Animal; Hyperkinesis; Male; Oxidopamine; Propylamines; Rats; Rats, Sprague-Dawley; Time Factors | 2005 |
Dimensional analysis of ADHD subtypes in rats.
Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Cluster Analysis; Disease Models, Animal; Disruptive, Impulse Control, and Conduct Disorders; Environment; Habituation, Psychophysiologic; Locomotion; Male; Methylphenidate; Photic Stimulation; Propylamines; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Time Factors; Treatment Outcome | 2007 |
Atomoxetine reverses nicotine withdrawal-associated deficits in contextual fear conditioning.
Topics: Adrenergic Uptake Inhibitors; Analysis of Variance; Animals; Atomoxetine Hydrochloride; Behavior, Animal; Conditioning, Psychological; Disease Models, Animal; Dose-Response Relationship, Drug; Fear; Freezing Reaction, Cataleptic; Male; Mice; Mice, Inbred C57BL; Nicotine; Nicotinic Agonists; Propylamines; Substance Withdrawal Syndrome | 2007 |
Atomoxetine increases histamine release and improves learning deficits in an animal model of attention-deficit hyperactivity disorder: the spontaneously hypertensive rat.
Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Disease Models, Animal; Histamine; Injections, Intraperitoneal; Learning; Male; Maze Learning; Memory; Prefrontal Cortex; Propylamines; Rats; Rats, Inbred SHR; Water | 2008 |
Post-injury atomoxetine treatment improves cognition following experimental traumatic brain injury.
Topics: Adrenergic Uptake Inhibitors; Animals; Atomoxetine Hydrochloride; Brain; Brain Injuries; Catecholamines; Cognition; Cognition Disorders; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Male; Maze Learning; Norepinephrine Plasma Membrane Transport Proteins; Propylamines; Rats; Rats, Sprague-Dawley; Recovery of Function; Time Factors; Treatment Outcome | 2008 |